Advances in Percutaneous Patent Foramen Ovale Closure: From the Procedure to the Echocardiographic Guidance

J Clin Med. 2022 Jul 11;11(14):4001. doi: 10.3390/jcm11144001.

Abstract

Percutaneous patent foramen ovale (PFO) closure by traditional, double disc occluder devices was shown to be safe for patients with PFO, and more effective than prolonged medical therapy in preventing recurrent thromboembolic events. The novel suture-mediated "deviceless" PFO closure system overcomes most of the risks and limitations associated with the traditional PFO occluders, appearing to be feasible in most interatrial septum anatomies, even if data about its long-term effectiveness and safety are still lacking. The aim of the present review was to provide to the reader the state of the art about the traditional and newer techniques of PFO closure, focusing both on the procedural aspects and on the pivotal role of transesophageal echocardiography (TEE) in patient's selection, peri-procedural guidance, and post-interventional follow-up.

Keywords: Amplatzer PFO Occluder; Gore Cardioform Septal Occluder; NobleStitch; intracardiac echocardiography (ICE); patent foramen ovale (PFO); transesophageal echocardiography (TEE).

Publication types

  • Review

Grants and funding

This research received no external funding.